MolPharm xPharm- The Comprehensive Pharmacology Reference

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by KATZ, R.
Right arrow Articles by JOHNSON, D. F.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by KATZ, R.
Right arrow Articles by JOHNSON, D. F.

Molecular Pharmacology, Vol 13, 615-620, Copyright © 1977 by the American Society for Pharmacology and Experimental Therapeutics

Interactions of Biogenic Amines with Organic Phosphate: A Proposed Model in Vitro for Study of Biological Interactions by 31P Nuclear Magnetic Resonance

ROBERT KATZ 1, HERMAN J. C. YEH 2, and DAVID F. JOHNSON 2

1 Mid-Atlantic Research Institute, Bethesda, Maryland 20014
2 Microanalytical Services and Instrumentation Section, Laboratory of Chemistry, National Institute of Arthritis, Metabolism, and Digestive Diseases, National Institutes of Health, Bethesda, Maryland 20014

The interaction between 31P-containing substrates, 4-deoxypyridoxine phosphate and monomethyl phosphate, and a series of protonated biogenic amines has been quantitated by use of [31P]-1H nuclear magnetic double resonance and titration. The difference in the phosphorus chemical shifts with and without amine in deuterated water indicated that optimal biogenic amine-phosphate interaction appears to require the presence of both a catechol ring and a beta-hydroxyl group in the ethylamine side chain. This is in good agreement with pharmacological measurements in vitro of biogenic amine retention by storage vesicles of rat heart adrenergic nerve terminals, indicating that phosphate could be involved in binding of biogenic amines in these vesicles. The model in vitro presented could provide a rapid, efficient method for biological evaluation of various drug-receptor systems involving phosphate-amine interactions.

Note:
ACKNOWLEDGMENTS We thank Drs. C. R. Creveling, J. Daly, and I. Kopin for useful comments and discussions, and Mrs. L. Weber and S. Paper for their assistance in manuscript preparation.

Submitted on June 21, 1976
Accepted on February 22, 1977







Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
 Molecular Interventions Drug Metabolism and Disposition

Copyright © 1977 by the American Society for Pharmacology and Experimental Therapeutics